- Home
- REBN vs IMNN Comparison
REBN vs IMNN Comparison
Compare REBN & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REBN
- IMNN
- Stock Information
- Founded
- REBN 2015
- IMNN 1982
- Country
- REBN United States
- IMNN United States
- Employees
- REBN N/A
- IMNN N/A
- Industry
- REBN Restaurants
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- REBN Consumer Discretionary
- IMNN Health Care
- Exchange
- REBN Nasdaq
- IMNN Nasdaq
- Market Cap
- REBN 13.5M
- IMNN 13.6M
- IPO Year
- REBN 2022
- IMNN 1985
- Fundamental
- Price
- REBN $2.77
- IMNN $0.88
- Analyst Decision
- REBN
- IMNN Strong Buy
- Analyst Count
- REBN 0
- IMNN 2
- Target Price
- REBN N/A
- IMNN $21.50
- AVG Volume (30 Days)
- REBN 104.9K
- IMNN 115.3K
- Earning Date
- REBN 03-31-2025
- IMNN 05-12-2025
- Dividend Yield
- REBN N/A
- IMNN N/A
- EPS Growth
- REBN N/A
- IMNN N/A
- EPS
- REBN N/A
- IMNN N/A
- Revenue
- REBN $5,928,533.00
- IMNN N/A
- Revenue This Year
- REBN $335.98
- IMNN N/A
- Revenue Next Year
- REBN N/A
- IMNN N/A
- P/E Ratio
- REBN N/A
- IMNN N/A
- Revenue Growth
- REBN 7.63
- IMNN N/A
- 52 Week Low
- REBN $1.03
- IMNN $0.64
- 52 Week High
- REBN $8.80
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- REBN 35.08
- IMNN 45.56
- Support Level
- REBN $2.89
- IMNN $0.82
- Resistance Level
- REBN $3.50
- IMNN $0.98
- Average True Range (ATR)
- REBN 0.37
- IMNN 0.06
- MACD
- REBN -0.04
- IMNN -0.01
- Stochastic Oscillator
- REBN 29.08
- IMNN 41.64
About REBN Reborn Coffee Inc.
Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.
About IMNN Imunon Inc.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.